INO
Inovio Pharmaceuticals Inc
Price:  
1.99 
USD
Volume:  
694,907.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO WACC - Weighted Average Cost of Capital

The WACC of Inovio Pharmaceuticals Inc (INO) is 7.8%.

The Cost of Equity of Inovio Pharmaceuticals Inc (INO) is 8.50%.
The Cost of Debt of Inovio Pharmaceuticals Inc (INO) is 6.65%.

Range Selected
Cost of equity 7.30% - 9.70% 8.50%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 6.30% - 7.00% 6.65%
WACC 6.8% - 8.9% 7.8%
WACC

INO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.74 0.86
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.22 0.22
Cost of debt 6.30% 7.00%
After-tax WACC 6.8% 8.9%
Selected WACC 7.8%